Navigation Links
DiFUSION Technologies Completes Successful Testing of Antimicrobial Spinal Implant
Date:1/26/2009

CleanFUZE(TM) antimicrobial device to significantly reduce surgical site infections (SSIs) and potentially save the healthcare system $150 million dollars annually

AUSTIN, Texas, Jan. 26 /PRNewswire/ -- DiFUSION Technologies, Inc., a medical device company targeting the orthopaedic market, has successfully completed a series of laboratory tests of its silver ion-based antimicrobial technology designed to mitigate Surgical Site Infections (SSIs) in spinal surgery. The technology will be incorporated into DiFUSION's first spinal implant CleanFUZE(TM). Laboratory tests validate the controlled antimicrobial release of ionic silver and antimicrobial efficacy, achieving a 5 log reduction in microbial counts which is 99.999% effective. Currently, no antibiotic can achieve this efficacy.

In response to the rising incidence of SSIs within spinal surgery, which have been reported in large studies to range from 2.5% to 13%, DiFUSION has developed CleanFUZE(TM), an antimicrobial PEEK spinal interbody cage capable of stopping biofilm formation in the bone graft site and eliminating 650 types of bacteria including antibiotic-resistant bacteria such as MRSA for up to four weeks postoperatively. DiFUSION's solution will not only improve infection ratios, it will also save the patient from additional surgery, weeks of IV antibiotics and in some cases life long exposure to oral suppressive antibiotics, amputation and even death; benefits that will impact surgeons, patients, hospitals and insurance carriers.

"DiFUSION is targeting a problem that costs hospitals and insurance carriers over $100,000 per SSI incidence, and CleanFUZE(TM) has the potential to not only obviate spinal surgical site infections, but also save hospitals millions of dollars a year in associated costs to treat these infections," said Dr. Peter Whang, a member of DiFUSION's scientific advisory board and an Assistant Professor in the Departmen
'/>"/>

SOURCE DiFUSION Technologies, Inc.
Copyright©2009 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4

Related biology technology :

1. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
2. Healthcare Technologies Calls for a Shareholders Meeting to Approve the Nexgen Biofuels Transaction
3. Healthcare Technologies Reports Loss for 2007 Second Quarter & Six Months Results
4. BioMaxx Systems Inc. Signs Engagement Letter With Alcofuel Technologies for Provision of an Ethanol Micro-Refinery
5. Amyris Biotechnologies Co-Founder Neil Renninger Named to Technology Reviews Prestigious TR35 List of Top Young Innovators
6. China Medical Technologies to Participate in the Morgan Stanleys 2007 China Medical Corporate Day
7. Pathway Medical Technologies Adds Joe Rafferty as VP, Sales, and Moves To Larger Facility to Accommodate Rapid Growth
8. Operon Biotechnologies and DNA2.0 Announce Co-Marketing and Technology Development Partnership
9. Emisphere Technologies, Inc. Appoints Paul Lubetkin as Vice President and General Counsel
10. Microchip Biotechnologies, Inc. Secures Exclusive License to Use New University of Alberta Technology for Developing Microfluidic Devices
11. DNA Sequencing Equipment Market to Fragment and Grow as Competition, New Technologies Develop
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2013)... 19, 2013   NineSigma , Inc., of ... following its launch, NineSights.com is now the ... for the worldwide community of innovators. From ... sustainability experts, NineSights stands out for its large community ... and technical disciplines, all vetted by NineSigma. The community ...
(Date:6/19/2013)... Bloomington, Indiana (PRWEB) June 19, 2013 ... Valentine joined the speaking faculty at 2013’s BioLogistics ... , The conference, coordinated by Cold Chain IQ ... surrounding biologics. This “complexity” is, in part, attributed ... medicine. , “Implicit within these trends is ...
(Date:6/19/2013)... San Diego, CA (PRWEB) June 19, 2013 ... quality pipettes, Pipette.com is now stocked with Simport’s Dropette® ... , all aimed at the customer doing basic biology, ... blood work, and serology). , For over 35 years, ... and disposable plastic labware - products like the Simport ...
(Date:6/18/2013)... 18, 2013 (PRWEB) June 18, 2013 ... attendance system in North America, has introduced AccountLinx ... data and payroll records between ExakTime’s software and ... automates ExakTime software setup and keeps employee databases ... data from a business’ current payroll software, directly ...
Breaking Biology Technology:NineSigma Evolves Global Open Innovation through Social Media Platform, NineSights 2NineSigma Evolves Global Open Innovation through Social Media Platform, NineSights 3BioConvergence® Presents at BioLogistics Summit on Risk Matrix for Biosamples during Shipment 2Leading Pipette Distributor Pipette.com Now Stocks Transfer Pipettes: Simport’s Dropette and Heathrow Scientific Disposable Plastic Transfer Pipettes 2ExakTime Introduces AccountLinx Plus 2
... Aug. 21 /Xinhua-PRNewswire-FirstCall/ --,China-Biotics, Inc. (OTC ... leading Chinese firm specializing in the ... probiotics products,today announced it signed a ... Ltd. ("Square Pharmaceutical") to supply probiotics ...
... 29% and adjusted EPS* of $0.35 ... increased 218% -, - Total Fiscal Year Revenues of $79.8M increased 15% ... $0.99 increased ... reported the results for its fourth quarter and fiscal,year ended June 30, 2008., Fourth ...
... YORK, MUNICH, Germany and AMSTERDAM, Netherlands, Aug. ... B.V., the,pan-European specialty pharmaceutical company, today announced ... million revenue interest acquisition financing,agreement to fund ... other markets, from Procter & Gamble Pharmaceuticals. ...
Cached Biology Technology:China-Biotics, Inc. Continues to Broaden Bulk Additives Client Base 2China-Biotics, Inc. Continues to Broaden Bulk Additives Client Base 3Kensey Nash Reports Fourth Quarter and Fiscal Year 2008 Results 2Kensey Nash Reports Fourth Quarter and Fiscal Year 2008 Results 3Kensey Nash Reports Fourth Quarter and Fiscal Year 2008 Results 4Kensey Nash Reports Fourth Quarter and Fiscal Year 2008 Results 5Kensey Nash Reports Fourth Quarter and Fiscal Year 2008 Results 6Kensey Nash Reports Fourth Quarter and Fiscal Year 2008 Results 7Kensey Nash Reports Fourth Quarter and Fiscal Year 2008 Results 8Kensey Nash Reports Fourth Quarter and Fiscal Year 2008 Results 9Kensey Nash Reports Fourth Quarter and Fiscal Year 2008 Results 10Kensey Nash Reports Fourth Quarter and Fiscal Year 2008 Results 11Kensey Nash Reports Fourth Quarter and Fiscal Year 2008 Results 12Kensey Nash Reports Fourth Quarter and Fiscal Year 2008 Results 13Kensey Nash Reports Fourth Quarter and Fiscal Year 2008 Results 14Kensey Nash Reports Fourth Quarter and Fiscal Year 2008 Results 15Kensey Nash Reports Fourth Quarter and Fiscal Year 2008 Results 16Kensey Nash Reports Fourth Quarter and Fiscal Year 2008 Results 17Kensey Nash Reports Fourth Quarter and Fiscal Year 2008 Results 18Kensey Nash Reports Fourth Quarter and Fiscal Year 2008 Results 19Kensey Nash Reports Fourth Quarter and Fiscal Year 2008 Results 20Kensey Nash Reports Fourth Quarter and Fiscal Year 2008 Results 21TVM Capital, Signet Healthcare Partners and Paul Capital Healthcare Enter into euro 26 Million Financing of SpePharm 2TVM Capital, Signet Healthcare Partners and Paul Capital Healthcare Enter into euro 26 Million Financing of SpePharm 3TVM Capital, Signet Healthcare Partners and Paul Capital Healthcare Enter into euro 26 Million Financing of SpePharm 4TVM Capital, Signet Healthcare Partners and Paul Capital Healthcare Enter into euro 26 Million Financing of SpePharm 5
(Date:6/18/2013)... of Molecular Biology, has been honored as a ... Torrent is being recognized for his outstanding research, ... antimicrobial regions in proteins. Luis Rivas, Centro de ... algorithm to interrogate full genomes in order to ... results." , Torrent obtained his Ph.D. from ...
(Date:6/18/2013)... for Molecular Pathology is proud to announce it will ... (FASEB) on July 1, 2013. The FASEB Board approved ... , The 26 constituent societies of FASEB represent more ... the advancement of research and education in biological and ... important now than ever," said Jennifer L. Hunt, MD, ...
(Date:6/18/2013)... a chemical modification of DNA and this modification ... DNA sequence. Until now, scientists believed that this ... genes. Today, a team of researchers from the ... Dermitzakis, Louis-Jeantet Professor at the Faculty of Medicine, ... and that DNA methylation may play both a ...
Breaking Biology News(10 mins):The American Society for Microbiology honors Marc Torrent 2The secret of DNA methylation 2
... is a growing human health concern. Researchers around ... to be present in surface waters and sediments, ... In a recent article in the November-December issue ... State University (CSU) describe a study to find ...
... morality gives but a slight or no advantage to ... men of the same tribe...an advancement in the standard ... one tribe over another. With these ... and pro-social behaviors individuals behaving for the good of ...
... Britain over the past 17 years for extracting oil is ... heavy oilfield in Canada. Duvernay Petroleum is to ... the University of Bath at its site at Peace River ... is very viscous, like syrup, or even solid in its ...
Cached Biology News:Manure management reduces levels of antibiotics and antibiotic resistance genes 2Group selection, a theory whose time has come...again 2Massive Canadian oilfield could be exploited using new UK system 2Massive Canadian oilfield could be exploited using new UK system 3
Human Cystatin A MAb (Clone 224705)...
... Molecular Probes is pleased to ... for the ultrasensitive detection of primary ... at Indiana University, the ATTO-TAG reagents ... o-phthaldialdehyde (OPA), naphthalene-2,3-dicarboxaldehyde (NDA) and anthracene-2,3-dicarboxaldehyde, ...
...
Anti-SDF-1β/PBSF affinity isolated antibody lyophilized powder Lyophilized from a 0.2 μm filtered solution in phosphate buffered saline recombinant human SDF-1β/PBSF expressed in E....
Biology Products: